Literature DB >> 35429022

Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters.

Cheng-Hsien Hung1, Tsung-Yuan Yang2,3, James Cheng-Chung Wei4,5,6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35429022      PMCID: PMC9111426          DOI: 10.1111/apt.16872

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


× No keyword cloud information.
Dear Editors, We read with great interest the article “Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments” by Kokkotis et al. The authors conducted a systematic review and meta‐analysis to evaluate COVID‐19 outcomes in patients receiving anti‐TNF treatments. While acknowledging these results, we would also like to highlight several methodological issues and provide our perspective. First, was the systematic review registered before being conducted, as no registration information was provided? Registration of systematic reviews is important to improve transparency and avoid potential bias, including selection bias and selective reporting bias, and to confirm the reproducibility of the study. Second, the search strategy should be more comprehensive. The authors only searched PubMed and SCOPUS, and we suggest that additional databases such as Embase, Web of Science, or The Cochrane Library could be used to search for additional literature, which would make the results more convincing. In addition, we were surprised that search keywords used the abbreviation “anti‐TNF” instead of “tumor necrosis factor inhibitors” or the MeSH term. Many relevant articles will have been missed. Third, the authors only used funnel plots to detect publication bias. However, the funnel plot is not a quantitative analysis and its interpretation is not precise. We suggest using Egger’s regression test or the Begg and Mazumdar rank correlation test to detect publication bias. Fourth, there are residual confounders that should be considered, such as different diseases and different types of drugs. We suggest that the authors perform subgroup analysis for disease type and drug type (monoclonal antibodies or receptor antagonists). In addition, many of the studies were conducted during the peak of the epidemic in 2020, which may have resulted in the underestimation of hospitalizations due to the shortage of medical resources. Moreover, some patients may not have been able to access healthcare. We respectfully thank Kokkotis et al. for providing us with a valuable meta‐analysis. Nevertheless, the authors should adopt a more comprehensive search strategy and appropriate methodology to avoid inaccurate results.

CONFLICT OF INTEREST

The authors have declared no conflicts of interest.
  5 in total

1.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

2.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

3.  Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.

Authors:  Georgios Kokkotis; Konstantina Kitsou; Ioannis Xynogalas; Vana Spoulou; Gkikas Magiorkinis; Ioannis Trontzas; Panagiotis Trontzas; Garyphallia Poulakou; Konstantinos Syrigos; Giorgos Bamias
Journal:  Aliment Pharmacol Ther       Date:  2021-12-08       Impact factor: 8.171

4.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  BMJ       Date:  2021-03-29

5.  The Coronavirus Disease 2019 Pandemic's Effect on Critical Care Resources and Health-Care Providers: A Global Survey.

Authors:  Sarah Wahlster; Monisha Sharma; Ariane K Lewis; Pratik V Patel; Christiane S Hartog; Gemi Jannotta; Patricia Blissitt; Erin K Kross; Nicholas J Kassebaum; David M Greer; J Randall Curtis; Claire J Creutzfeldt
Journal:  Chest       Date:  2020-09-11       Impact factor: 9.410

  5 in total
  1 in total

1.  Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply.

Authors:  Georgios Kokkotis; Konstantina Kitsou; Giorgos Bamias
Journal:  Aliment Pharmacol Ther       Date:  2022-05       Impact factor: 9.524

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.